Altogether, the biokinetic data for the examined NBs and potential therapeutic effects for CLB-GE already at these low amounts, clearly demonstrate that 177Lu-octreotate therapy can be very effective in these types of NB. This evidence concerns the gene CLYBL and neuroblastoma.